[Involvement of TGFbeta1 in fibrotic diseases: role of its effectors, the Smad proteins]

Rev Med Interne. 2006 Jan;27(1):46-9. doi: 10.1016/j.revmed.2005.10.004. Epub 2005 Nov 22.
[Article in French]

Abstract

Introduction: Transforming Growth Factor beta 1 (TGFbeta1) is a key cytokine in the development of fibrotic diseases which are characterized by a pathological excess of extracellular matrix involving multiple organs.

Exegesis: To induce its biological effects, TGFbeta1 interacts with Ser/Thr kinase receptor complexes. The polypeptide binding to the receptors induces TGFbeta intracellular mediator phosphorylation and namely Smad proteins. Upon phosphorylation the latter form protein complexes which are then translocated to the nucleus where they participate to matrix gene regulation.

Conclusion: We will summarize the literature on the involvement of TGFbeta1 through the Smad proteins in fibrotic diseases.

Publication types

  • English Abstract

MeSH terms

  • Fibrosis / physiopathology*
  • Humans
  • Kinetics
  • Smad Proteins / physiology*
  • Transforming Growth Factor beta / physiology*
  • Transforming Growth Factor beta1

Substances

  • Smad Proteins
  • TGFB1 protein, human
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1